Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03096132 · ClinicalTrials.gov registry record · NA
FRESH-DOSE: Families Responsibility Education Support Health-Dual Options for Sustained Effectiveness
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT03096132: Completed NA study, sponsored by University of California, San Diego.
NCT03096132 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03096132, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate whether a less intensive intervention, Guided Self-Help Family Based Treatment (gshFBT), is non-inferior to the more intensive Family Based Treatment (FBT) for childhood obesity on child weight loss over 18-months. Cost-effectiveness of both treatments will also be compared.
Primary Outcome
BMI; BMIz
Interventions
- BEHAVIORAL Family Based Behavioral Treatment
- BEHAVIORAL Guided Self-Help Fam. Based Bx Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2017-04-18 |
| Est. Completion | 2023-02-03 |
| Phase | NA |
What the finished NCT03096132 record still lists
NCT03096132 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Family Based Behavioral Treatment is the first listed.
NCT03096132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03096132 about?
NCT03096132 is a clinical study titled "FRESH-DOSE: Families Responsibility Education Support Health-Dual Options for Sustained Effectiveness". The objective of the study is to evaluate whether a less intensive intervention, Guided Self-Help Family Based Treatment (gshFBT), is non-inferior to the more intensive Family Based Treatment (FBT) for childhood obesity on child weight loss over 18-months. Cost-effectiveness of both treatments will ...
What is the current status of trial NCT03096132?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2017-04-18. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT03096132?
The interventions under investigation include: Family Based Behavioral Treatment (BEHAVIORAL), Guided Self-Help Fam. Based Bx Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03096132?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03096132's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI